The increase in immunosuppression and its role in the development of malignant lesions
- 1 November 1985
- journal article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 30 (3) , 139-144
- https://doi.org/10.1002/jso.2930300303
Abstract
The first evidence that a major operation results in immunosuppression appeared in 1957. A few years later, numerous articles appeared in the medical literature showing that the same effect took place in the human being. When kidney transplantation was begun, it was soon learned that immunosuppression was necessary to obtain good results. Soon after suppression was adopted it was noted that malignancies were being encountered. The same was true with cardiac transplantation. Within the many types of immunodeficiency's, malignant lesions are significantly encountered in only one‐AIDS.Keywords
This publication has 21 references indexed in Scilit:
- Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancerCancer, 1985
- SEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROMEThe Lancet, 1984
- Subcutaneous seeding of pancreatic carcinoma along a transhepatic biliary catheter tractThe British Journal of Radiology, 1983
- Dissemination of CancerSouthern Medical Journal, 1982
- OUTBREAK OF BURKITT'S-LIKE LYMPHOMA IN HOMOSEXUAL MENThe Lancet, 1982
- Tumour-induced specific suppression: a limitation to immunotherapyImmunology Today, 1982
- Urinary immunoglobulin A in the diagnosis of bladder cancerJournal of Surgical Oncology, 1981
- Anesthesia and Surgery: A Double‐Edged Sword for the Cancer PatientJournal of Surgical Oncology, 1980
- Ultrasound: A new immunosuppressantClinical Immunology and Immunopathology, 1979
- Role of Operative Stress on the Resistance of the Experimental Animal to Inoculated Cancer CellsAnnals of Surgery, 1958